Zolpidem tartrate

This classification denotes a sedative and hypnotic with the molecular formula 2C19H21N3O.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WY6W63843K, chemically known as n,n,6-trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide but more generally known as zolpidem tartrate, which bears US NIH Compound Identifier 5732. European Medicines Agency schedules Zolpidem tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05192MIG. Most nations, for tariff and trade purposes, schedule zolpidem tartrate under HS 29339990 and SITC 51577. As of Q4 2014, ZOLPIDEM TARTRATE remains US FDA's Preferred Term for this commodity. Zolpidem tartrate bears US NLM identifiers UMLS ID C0724725 and NCI Concept Code C29553. SMILES: CC1CCC(CC1)C2C(N3CC(CCC3N2)C)CC(=O)N(C)C.CC1CCC(CC1)C2C(N3CC(CCC3N2)C)CC(=O)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.